Jason Chien, MD

Jason Chien currently serves as the Gilead global lead for respiratory viruses. In this role, Jason helps Gilead define the overall commercial and development strategy for addressing the respiratory virus related unmet need in adults and children. Prior to joining Gilead in 2011, Jason was on faculty at the University of Washington and at Fred Hutchinson Cancer Research Center, where his scientific contributions in the field of bone marrow transplantation serve as the foundation of clinical management guidelines, which still remains accepted by the global transplant community as standard of care for monitoring and treatment of pulmonary complications such as bronchiolitis obliterans syndrome. Jason received his BA from University of Michigan, his MD from New Jersey Medical School, and an MS in Genetic Epidemiology from University of Washington. He completed clinical and research fellowships in infectious diseases at Case Western University Hospital and pulmonary and critical care medicine at the University of Washington.